Latest Insider Transactions at Core Scientific, Inc. (CORZ)
This section provides a real-time view of insider transactions for Core Scientific, Inc. (CORZ). The data is sourced from Form 4 filings with the SEC, which are filed by insiders of Core Scientific, Inc. to disclose their transactions in the company's securities. By reviewing this information, investors can gain insights into the trading activity of Core Scientific, Inc.'s insiders and make more informed investment decisions.
Insider Transaction List
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Jun 14
2024
|
Todd M Duchene |
SELL
Open market or private sale
|
Direct |
26,230
-6.67%
|
$236,070
$9.9 P/Share
|
|
Jun 14
2024
|
Adam Taylor Sullivan Chief Executive Officer |
BUY
Grant, award, or other acquisition
|
Direct |
3,823,363
+23.55%
|
-
|
|
Jun 13
2024
|
Todd M Duchene |
SELL
Open market or private sale
|
Direct |
3,770
-0.95%
|
$33,930
$9.99 P/Share
|
|
May 27
2024
|
Todd A Becker |
BUY
Grant, award, or other acquisition
|
Direct |
175,239
+23.06%
|
-
|
|
May 27
2024
|
Jordan Levy |
BUY
Grant, award, or other acquisition
|
Direct |
175,239
+35.71%
|
-
|
|
May 27
2024
|
Jarrod M Patten |
BUY
Grant, award, or other acquisition
|
Direct |
175,239
+25.35%
|
-
|
|
May 27
2024
|
Jeffrey David Booth |
BUY
Grant, award, or other acquisition
|
Direct |
175,239
+35.71%
|
-
|
|
May 27
2024
|
Yadin Rozov |
BUY
Grant, award, or other acquisition
|
Direct |
175,239
+26.91%
|
-
|
|
May 27
2024
|
Eric Stanton Weiss |
BUY
Grant, award, or other acquisition
|
Direct |
175,239
+33.65%
|
-
|
|
May 13
2024
|
Denise Marie Brucia Sterling Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
4,261
-3.15%
|
$12,783
$3.66 P/Share
|
|
Mar 15
2024
|
Todd A Becker |
BUY
Open market or private purchase
|
Direct |
130,000
+49.2%
|
$390,000
$3.16 P/Share
|
|
Mar 15
2024
|
Jarrod M Patten |
BUY
Open market or private purchase
|
Direct |
100,000
+50.0%
|
$300,000
$3.32 P/Share
|
|
Mar 15
2024
|
Yadin Rozov |
BUY
Open market or private purchase
|
Direct |
80,000
+50.0%
|
$240,000
$3.07 P/Share
|
|
Mar 15
2024
|
Adam Taylor Sullivan Chief Executive Officer |
BUY
Open market or private purchase
|
Direct |
65,300
+41.06%
|
$195,900
$3.06 P/Share
|
|
Mar 15
2024
|
Eric Stanton Weiss |
BUY
Open market or private purchase
|
Direct |
15,000
+50.0%
|
$45,000
$3.03 P/Share
|
|
Feb 22
2024
|
Todd M Duchene |
SELL
Payment of exercise price or tax liability
|
Direct |
24,153
-5.73%
|
$72,459
$3.23 P/Share
|
|
Feb 22
2024
|
Denise Marie Brucia Sterling Chief Financial Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
16,617
-10.94%
|
$49,851
$3.23 P/Share
|
|
Jan 23
2024
|
Darin Feinstein Director |
BUY
Grant, award, or other acquisition
|
Indirect |
1,294,195
+50.0%
|
-
|
|
Jan 23
2024
|
Darin Feinstein Director |
BUY
Grant, award, or other acquisition
|
Direct |
31,337,169
+26.33%
|
-
|
|
Jan 23
2024
|
Darin Feinstein Director |
SELL
Sale (or disposition) back to the issuer
|
Indirect |
1,294,195
-100.0%
|
-
|
|
Jan 23
2024
|
Darin Feinstein Director |
SELL
Sale (or disposition) back to the issuer
|
Direct |
30,483,592
-100.0%
|
-
|
|
Jan 23
2024
|
Matt Minnis Director |
BUY
Grant, award, or other acquisition
|
Indirect |
29,453,080
+25.57%
|
-
|
|
Jan 23
2024
|
Matt Minnis Director |
SELL
Sale (or disposition) back to the issuer
|
Indirect |
29,111,651
-100.0%
|
-
|
|
Jan 23
2024
|
Jarvis V. Hollingsworth |
BUY
Grant, award, or other acquisition
|
Direct |
1,211,956
+50.0%
|
-
|
|
Jan 23
2024
|
Jarvis V. Hollingsworth |
SELL
Sale (or disposition) back to the issuer
|
Direct |
1,211,956
-100.0%
|
-
|
|
Jan 23
2024
|
Denise Marie Brucia Sterling Chief Financial Officer |
BUY
Grant, award, or other acquisition
|
Direct |
1,518,472
+50.0%
|
-
|
|
Jan 23
2024
|
Denise Marie Brucia Sterling Chief Financial Officer |
SELL
Sale (or disposition) back to the issuer
|
Direct |
1,518,472
-100.0%
|
-
|
|
Jan 23
2024
|
Adam Taylor Sullivan Chief Executive Officer |
BUY
Grant, award, or other acquisition
|
Direct |
28,453
+50.0%
|
-
|
|
Jan 23
2024
|
Michael J Levitt Director |
BUY
Grant, award, or other acquisition
|
Indirect |
21,154,604
+30.81%
|
-
|
|
Jan 23
2024
|
Michael J Levitt Director |
BUY
Grant, award, or other acquisition
|
Direct |
20,179,833
+25.21%
|
-
|
|
Jan 23
2024
|
Michael J Levitt Director |
SELL
Sale (or disposition) back to the issuer
|
Indirect |
20,244,350
-100.0%
|
-
|
|
Jan 23
2024
|
Michael J Levitt Director |
SELL
Sale (or disposition) back to the issuer
|
Direct |
20,094,478
-100.0%
|
-
|
|
Jan 23
2024
|
Dr Kneeland Youngblood |
BUY
Grant, award, or other acquisition
|
Direct |
400,038
+50.0%
|
-
|
|
Jan 23
2024
|
Dr Kneeland Youngblood |
SELL
Sale (or disposition) back to the issuer
|
Direct |
400,038
-100.0%
|
-
|
|
Jan 23
2024
|
Todd M Duchene |
BUY
Grant, award, or other acquisition
|
Direct |
3,751,387
+25.68%
|
-
|
|
Jan 23
2024
|
Todd M Duchene |
SELL
Sale (or disposition) back to the issuer
|
Direct |
3,700,040
-100.0%
|
-
|
|
Dec 01
2022
|
Todd M Duchene |
SELL
Payment of exercise price or tax liability
|
Direct |
13,119
-0.35%
|
$0
$0.14 P/Share
|
|
Nov 01
2022
|
Todd M Duchene |
SELL
Payment of exercise price or tax liability
|
Direct |
13,119
-0.35%
|
$0
$0.18 P/Share
|
|
Oct 03
2022
|
Todd M Duchene |
SELL
Payment of exercise price or tax liability
|
Direct |
13,119
-0.35%
|
$13,119
$1.37 P/Share
|
|
Sep 19
2022
|
Brian Neville Chief Accounting Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
2,436
-0.54%
|
$2,436
$1.66 P/Share
|
|
Sep 01
2022
|
Todd M Duchene |
SELL
Payment of exercise price or tax liability
|
Direct |
13,119
-0.35%
|
$26,238
$2.12 P/Share
|
|
Aug 24
2022
|
Todd M Duchene |
SELL
Payment of exercise price or tax liability
|
Direct |
13,119
-0.35%
|
$26,238
$2.74 P/Share
|
|
Aug 15
2022
|
Todd M Duchene |
BUY
Grant, award, or other acquisition
|
Direct |
1,200,000
+24.17%
|
-
|
|
Aug 15
2022
|
Michael J Levitt Director |
BUY
Grant, award, or other acquisition
|
Direct |
2,800,000
+12.23%
|
-
|
|
Aug 15
2022
|
Denise Marie Brucia Sterling Chief Financial Officer |
BUY
Grant, award, or other acquisition
|
Direct |
1,000,000
+39.71%
|
-
|
|
Jul 05
2022
|
Michael J Levitt Director |
SELL
Payment of exercise price or tax liability
|
Direct |
1,238,126
-6.68%
|
$1,238,126
$1.71 P/Share
|
|
Jul 01
2022
|
Todd M Duchene |
SELL
Payment of exercise price or tax liability
|
Direct |
13,119
-0.51%
|
$13,119
$1.51 P/Share
|
|
Jun 24
2022
|
Todd M Duchene |
SELL
Payment of exercise price or tax liability
|
Direct |
78,708
-2.96%
|
$157,416
$2.09 P/Share
|
|
Jun 13
2022
|
Stacie Olivares Director |
BUY
Grant, award, or other acquisition
|
Direct |
400,038
+50.0%
|
-
|
|
Jun 13
2022
|
Dr Kneeland Youngblood |
BUY
Grant, award, or other acquisition
|
Direct |
400,038
+50.0%
|
-
|